Why the study?
Increasing US endocarditis incidence involves higher-risk patients whose surgical candidacy may be resource-intensive, prohibitively high risk, or delayed by comorbidities.
Describes a multidisciplinary pathway for decision-making in the diagnosis and treatment of infectious endocarditis across four distinct clinical groups.
Answers are grounded in this paper and cite their sources.
Presents a multidisciplinary IE pathway; leaves open its impact on outcomes pending prospective validation.
Clinical pathways can be useful when disparate clinical-pathologic groups converge on a common diagnostic and therapeutic trajectory. The progressive increase in the incidence of endocarditis in the US has included higher-risk subjects whose candidacy for aggressive cardiac surgical intervention may be highly resource-intensive, prohibitively high risk, or delayed and possibly deferred by comorbidities. We sought to define the sequence, application, and resolution of multidisciplinary endocarditis team decision-making in 4 distinct clinical groups.
No takes yet. Share an insight, caveat, or question.
Gibbons et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: